3 results match your criteria: "Ospedale Policlinico San Martino-University of Genoa[Affiliation]"
DAA-PASS: A Prospective Evaluation of HCC Recurrence After Direct Acting Antiviral Therapy.
J Viral Hepat
February 2025
Clinica Universidad de Navarra, Pamplona, Spain.
Direct-acting antiviral (DAA) therapy is associated with a significant reduction in hepatocellular carcinoma (HCC) incidence among patients with cirrhosis, but data are conflicting about the risk of recurrence following DAA therapy. DAA-PASS was a prospective, pragmatic, observational study designed to estimate the risk of HCC recurrence associated with DAA therapy exposure during routine clinical care. Eligible patients were DAA treatment naive with Barcelona Clinic Liver Cancer (BCLC) stage A.
View Article and Find Full Text PDFThe safety of oral immunotherapy for food allergy during maintenance phase: Effect of counselling on adverse reactions.
World Allergy Organ J
January 2019
Department of Pediatrics, Allergy Unit, University of Messina, Messina, Italy.
Different View on Larynx Preservation Evidence-Based Treatment Recommendations.
J Clin Oncol
May 2018
Lisa Licitra, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori and University of Milan, Milan, Italy; Pierluigi Bonomo, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy; Giuseppe Sanguineti, Istituto Tumori Regina Elena, Rome, Italy; Almalina Bacigalupo, Ospedale Policlinico San Martino-University of Genoa, Genoa, Italy; Giacomo Giulio Baldi, Hospital of Prato, Prato, Italy; Sara Valerini, University Hospital of Modena, Modena, Italy; and Paolo Bruzzi, Ospedale Policlinico San Martino-University of Genoa, Genoa, Italy.